Logo for ContextVision

ContextVision Investor Relations Material

Latest events

Logo for ContextVision

Q1 2024

ContextVision
Logo for ContextVision

Q1 2024

8 May, 2024
Logo for ContextVision

Q4 2023

15 Feb, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from ContextVision

Access all reports
Segment Data
Access more data
Net sales by
Geography
Asia
Europe
America
Expenses by
Financials
ContextVision's solutions include GOPiCE, a pre-processing technology for medical images that reduces the noise in images and enhances the details in images; ANDROS CLINICiMAGE, an image analysis solution for prostate cancer; GENESISiMAGE, a visualization and image analysis software solution for gynecology exams; ANDROS iQA that supports physicians with visual information during quality control in mammography; BABYLON iQI that enables automatic detection of 7 different parameters of breast density in mammogram cases; and INFINITY FOCUS CONDENSER, an imaging analysis technology. The company was formerly known as Xenex AB. ContextVision AB was founded in 1983 and is headquartered in Stockholm, Sweden.